Mutations activating the KRAS GTPase or the BRAF kinase are frequent in colorectal cancer. Here, we 2 use inducible transgenic expression of KRAS G12V or BRAF V600E in intestinal organoids of mice to 3 investigate oncogenic signal transduction in the mitogen-activated protein kinase (MAPK) cascade 4 with cellular resolution. Using phospho-protein, reporter, and single cell transcriptome analyses, we 5 found that BRAF V600E triggered high ERK activity and downstream gene expression in all intestinal cell 6 types. Induction of BRAF V600E resulted in rapid epithelial disorganisation followed by organoid 7 disintegration, providing evidence for an upper limit of tolerable MAPK activity in the intestinal 8 epithelium. In contrast, transgenic expression of KRAS G12V activated ERK to a lesser extent and in a 9 cell type-specific pattern. Single cell RNA sequencing defined three intestinal cell types capable of 10 activating ERK: undifferentiated crypt cells, Paneth cells and a minority population of late-stage 11
Introduction 1 Multiple signalling pathways, including the Wnt/-Catenin and the mitogen-activated protein kinase 2 (MAPK) cascades, form a signalling network in cells of the intestinal epithelium [1] . Collectively, 3 activities within the signalling network control cellular turnover, that is, stem cell maintenance, cell 4 proliferation, differentiation into absorptive enterocyte and secretory cell lineages, and apoptosis. 5 Wnt/-Catenin and MAPK activities are regionalized within the folded single-layered intestinal 6 epithelium. Both are high in crypt bases harbouring stem cells and low in villus areas containing 7 differentiated enterocytes. 8
The MAPK module transduces signals downstream of receptor tyrosine kinases, such as EGFR, and 9 RAS family GTPases. MAPK comprises of three consecutively activated kinases, namely RAF, MEK and 10 ERK. Upon activation, ERK can phosphorylate and activate a series of transcription factors 11 orchestrating a complex cellular response that often is pro-proliferative [2] . In the normal intestine, 12 EGFR-RAS-MAPK is activated by ligands from the crypt microenvironment, which are secreted by e.g. 13 epithelial Paneth cells of the small intestine, Reg4+ secretory niche cells of the large intestine, or 14 adjacent fibroblasts [3, 4] . In colorectal cancer (CRC), MAPK activity is thought to be more cell-15 autonomous due to oncogenic mutations activating KRAS (in 40% of CRCs) or NRAS (5% of CRCs) [5] 16 or BRAF (10% of CRCs) [6] , or by de novo expression of EGFR ligands such as amphiregulin [7] . Activity 17 of the RAS-MAPK signal transduction module is a main determinant of cancer development and 18 therapy response [5, 6, 8] . 19
Recent studies suggest that the relationship between MAPK-activating mutations, MAPK signal 20 transduction and phenotypic outcome in CRC is complex: firstly, mutations in KRAS and BRAF are 21 associated with distinct CRC development routes: KRAS, but not BRAF, mutations frequently occur as 22 secondary events after mutations activating Wnt/-Catenin in the conventional CRC progression 23 sequence [9, 10] . Conversely, BRAF, but less frequently KRAS, mutations precede upregulation of 24 Wnt/-Catenin in the alternative serrated progression route [11, 12] . The observed disequilibrium 25 between KRAS and BRAF mutations in the conventional versus serrated pathways of CRC evolution 26 suggest the existence of functional differences, resulting in distinctive effects on clinical course and 27 treatment efficacy [13] . 28 Secondly, MAPK signal transduction appears to be heterogeneous in genetically identical CRC cells. 29 Cells at the invasive front frequently exhibited more MAPK activity compared to cells in central areas 30
of the same cancer, as judged by phosphorylation of ERK (p-ERK), and CRCs with activating KRAS 31 mutations retained regulation of MAPK [14] . Previous studies already showed heterogeneous Wnt/-32
Catenin activity in cancer specimens, suggesting a more general paradigm of graded pathway 33 although it contained a brush border as evidence of polarisation. Nuclei were pleomorphic and no 23 longer lined up basally but were scattered at different positions. Cells were still attached to each 24 other by desmosome bridges, indicating that the ongoing epithelial disorganisation was taking place 25 in the presence of lateral cell adhesion. 26
To ascertain whether the epithelial disorganisation provoked by BRAF V600E was correlated with MAPK 27 activity, we measured phosphorylation of ERK. We found that induction of BRAF V600E , but not 28 KRAS G12V , resulted in high phosphorylation levels of ERK in intestinal organoids, as determined by 29 capillary protein analysis ( Fig. 1D ). BRAF V600E -induced organoid disintegration could be counteracted 30 by inhibition of the BRAF-downstream MEK and ERK kinases using AZD6244/Selumetinib [29] and 31 BVD-523/Ulixertinib [30] , respectively, but not by inhibition of the upstream EGFR tyrosine kinase 32 receptor family using AZD8931/Sapitinib [31] (Fig. 1E) , showing that the induced phenotype is due to 33 6 excessive MAPK activity. Indeed, only 24 h of BRAF V600E induction activated almost all direct MAPK 1 target genes [32] , whereas conditional expression of KRAS G12V had no obvious effect on bulk organoid 2 transcription ( Supplementary Fig. 1 
15
To uncover potential cellular heterogeneity in the response to the oncogenes, we performed single 16 cell transcriptome analyses. We induced FLUC control, BRAF V600E and KRAS G12V -transgenic organoids 17 for 24 h, prepared single cell suspensions, and stained them with a fluorescent antibody against the 18 crypt cell marker CD44 [33] , and with a fluorescent dye to eliminate dead cells. We next sorted 19 single live and transgene-expressing organoid cells into two 96-well plates for RNA sequencing. We 20 acquired samples of CD44-high crypt and CD44-low villus cells. In total, we obtained transcriptomes 21 of 167 cells with >1000 detected genes per cell that were used for further analysis. Single cell 22 transcriptomes were assigned to six interconnected clusters with help of k-means clustering and 23 visualised in a t-SNE-based representation ( Fig Fig. 2A ; cluster 1 was assigned starting 27 cluster): undifferentiated CD44-high ISC and TA cell signature genes were enriched in clusters 1 and 2 28 while Paneth cell marker genes were highest in cluster 2, indicating the route for secretory crypt cells 29 differentiation; expression of enterocyte signature genes increased gradually in clusters 3-5, marking 30 the CD44-low absorptive lineage. 31
We next considered the distribution of cells expressing specific transgenes: FLUC control and 32 KRAS G12V -expressing cells intermingled throughout the clusters 1-5 of the normal cell differentiation 33 trajectories. BRAF V600E -expressing cells were in contrast depleted from the central clusters 2-4, but 1 formed the outsider cluster 6, composed entirely of BRAF-induced cells. BRAF V600E -positive cells in 2 cluster 6 uniformly expressed high levels of ERK target genes, regardless of whether they were sorted 3 as CD44-high or CD44-low ( Fig. 2C ). Cluster 6 also had high expression of Anxa10, which has been 4 identified as a marker for BRAF-positive serrated adenoma [36]( Supplementary Fig. 2 ). The single cell 5 analysis thus shows that BRAF V600E imposes a specific gene expression program onto intestinal cells, 6 independent of their prior differentiation state. Since mutant KRAS is one of the most frequent oncogenes in colon cancer, we were intrigued by the 3 absence of KRAS G12V -induced MAPK activity, phenotypes, or gene expression changes in our previous 4 assays. We hypothesized that its activity could be weak and restricted to specific cell types in the 5 normal intestine. To visualize ERK activity with single cell resolution in organoids, we employed the 6
Fra-1-based integrative reporter of ERK (FIRE) that translates ERK kinase activity into stability of a 7 nuclear yellow-green venus fluorescent protein ( Fig. 3A ) [22] . FIRE fluorescence in organoids cultured 8 in normal growth medium containing EGF was strong in crypt bases, whereas differentiated villus 9 tissue was largely FIRE-negative ( Fig. 2B ). In the absence of EGF from the medium, ERK activity in the 10 crypt base persisted, likely due to autocrine and paracrine signals from EGF-producing Paneth cells 11 [4] . 12
We next conditionally expressed the FLUC control, KRAS G12V , or BRAF V600E -encoding transgenes in 13 FIRE-transfected organoids ( Fig. 3C ). Transgene induction was often variable, as inferred by tdTomato 14 fluorescence, allowing to compare individual tdTomato-positive cells with transgene-negative 15 neighbouring tissue. tdTomato-FLUC control transgene expression had no influence on FIRE activity. 16
In contrast, expression of KRAS G12V resulted in increased FIRE signals in crypt cells, which consistently 17 displayed stronger reporter activity compared to adjacent KRAS G12V -negative cells. Surprisingly, a 18 large majority of villus cells remained FIRE negative, despite strong KRAS G12V positivity, as inferred 19 from tdTomato fluorescence. We confirmed the differential signal transduction from KRAS G12V to ERK 20 using phospho-ERK immunohistochemistry (Fig. 3D ). In line with our FIRE reporter data, p-ERK-21 positive cells were largely absent in the central differentiated (Ki67-negative) villus areas of 22 organoids, despite strong tdTomato-KRAS G12V positivity. Taken together, our results show that ERK 23 activity in differentiated villus epithelial cells can neither be induced by EGF in the medium nor by 24 induction of oncogenic KRAS G12V . However, when we induced BRAF V600E , we found widespread and 25 strong FIRE signals across the complete organoid ( Fig. 3C ). This suggests a strict and cell-type specific 26 control of signal transduction by oncogenic KRAS, but not BRAF in intestinal epithelial cells. 27
Since FIRE fluorescence was detected in cells responsive to KRAS G12V , we next used the reporter to 28 assist selection of cells for single cell sequencing. Our aim was to define cell types with high ERK 29 activity, either in response to KRAS G12V or as part of the normal cell hierarchy. For this, we induced 30 organoids with the integrated ERK reporter for KRAS G12V or FLUC, prepared single cell suspensions 31 and sorted cells by FACS into 96-well plates for transcriptome analysis ( Supplementary Fig. 3 ). We 32 focussed on single cells with high transgene (tdTomato) signal and either strong or weak FIRE (venus) 33 fluorescence ( Fig. 4A ). In total, we obtained 197 single cell transcriptomes. K-means clustering into 8 34 groups and t-SNE-based visualisation (Fig. 4B , C) revealed the cell type distribution. We found gene 1 expression patterns characteristic for immature and secretory cells in clusters 1-4. Cluster 1 was 2 enriched for ISC and TA marker genes, whereas clusters 2-4 were defined by Paneth cell signature 3 genes ( Fig 4D; Supplementary Fig. 4 ). Cluster 2 was enriched for the Paneth cell markers Lyz1 4 encoding Lysozyme [37] and several genes encoding Defensins, while other cluster-defining genes 5 such as Mptx1 and Agr2 in cluster 4 hint at a high degree of Paneth cell heterogeneity. Clusters 5-8 6 formed a differentiation trajectory for absorptive cells, with Ifabp1 as the top defining genes for 7 clusters 5-7 ( Supplementary Fig. 4 ) 8
Using this information, we assessed the distribution of transcriptomes derived from KRAS G12V -9
induced FIRE-high cells (Fig. 4C, D) . These were confined to distinct aggregates encompassing the 10 ISC/TA cell zone of cluster 1, as well as transcriptomes inhabiting the outer right rim of the tSNE 11 representation that we above assigned to be derived from late-stage enterocytes and Paneth cells. 12
Immunofluorescence microscopy using the Paneth cell marker Lysozyme confirmed high FIRE activity 13 in this cell type after KRAS G12V induction ( Supplementary Fig. 5 ). In contrast, a central area of the tSNE 14 plot encompassing the largest clusters 5 and 6 of bulk enterocytes was almost devoid of KRAS G12 -15 producing FIRE-high cells but harboured many KRAS G12V /FIRE-low cells, confirming that enterocytes 16 cannot activate ERK, even when expressing oncogenic KRAS G12V . 17
Inspection of the MAPK-driven ERK target signature in the clustered transcriptomes revealed a 18 complex picture ( Fig.4D ): KRAS G12V /FIRE-high cell transcriptomes of cluster 1 displayed low expression 19 of ERK signature genes, probably due to quickly diminishing ERK activity and transcription in 20 committed TA cells that transiently remain positive for FIRE, due to its integrative fluorescence 21 reporting characteristics [22] . In contrast, multiple FIRE-positive Paneth cells of clusters 2-4 and 22 enterocytes at the edge of clusters 7 and 8 displayed had ERK activity, as inferred from ERK target 23 gene expression. We hypothesize that the burst of ERK activity in late-stage enterocytes is directly or 24 indirectly related to the apoptotic process at the end of their life span. Indeed, a previous publication 25 has identified a role for ERK signals in cells neighbouring an apoptotic enterocyte [38] . It remains to 26 be tested whether the burst of ERK activity in some late-stage enterocytes is amplified by KRAS G12V ; 27 we found that isolated FIRE-positive cells were present in organoid villus domains regardless of activity in Fig. 4D ). Furthermore, activating KRAS mutations usually follow mutations activating the 20 Wnt/-Catenin pathway in conventional CRC progression [9] . We first analysed ERK phosphorylation 21 13 in intestines of induced transgenic mice carrying single or combined transgenes encoding stabilized 1 -Catenin (-Catenin stab ) and KRAS G12V (Fig. 5A) . We detected increased and regional ERK 2 phosphorylation in the proliferative zone, but not in differentiated enterocytes, following KRAS G12V 3 activation, which agrees with our reporter and transcriptome analyses. The increased ERK 4 phosphorylation did not extend into the crypt bases, likely due to lower levels of transgene induction 5 (see tdTomato staining in Fig. 5A, lower panels) . Again, some enterocytes at the tip of the villus were 6 strongly p-ERK-positive regardless of KRAS G12V induction, confirming our findings of isolated p-ERK-7 positive late-stage enterocytes in the previous assays. Interestingly, we also detected increased p-8 ERK levels in the proliferative zone of transgenic mice producing -Catenin stab . However, only in mice 9 with a double KRAS G12V --Catenin stab -encoding transgene, we observed many p-ERK-positive 10 enterocytes throughout the villi. In contrast, we found that ERK phosphorylation depended on 11 Wnt/-Catenin activity in organoids, since removal of the Wnt co-ligand R-Spondin from cultures 12 reduced p-ERK levels within 24h (Fig. 5B) . 13 We next assessed KRAS G12V -dependent proliferation and ERK phosphorylation in spheroid cells that 14 have undergone a switch to an adenoma-like phenotype after long-term activation of stabilized -15
Catenin and removal of the Wnt co-ligand R-Spondin ( Fig. 5C-E) . These cells largely phenocopy 16 adenoma of the conventional CRC progression pathway, i.e. an early stage in tumour evolution after 17 activation of the Wnt/-Catenin pathway, but before mutational MAPK activation [40] . We found 18 that adenomatous spheroids proliferate in the absence of EGF in the culture medium over several 19 passages, regardless of whether they express a transgene encoding -Catenin stab , or a transgene 20 encoding both -Catenin stab and KRAS G12V . To test for self-sufficiency of spheroid proliferation, we 21 used the EGFR inhibitor Gefitinib [41] to suppress residual autocrine or paracrine EGFR signals. Under 22 these conditions, the growth of -Catenin stab -induced spheroid cultures stalled, while combined -23 Catenin stab -and KRAS G12V -cultures maintained proliferation (Fig. 5B, C) . This observation contrasted 24 with organoids derived from normal intestinal tissue (that is, without long-term induction a -25 Catenin stab transgene), which were highly EGF dependent and could not employ KRAS G12V to sustain 26 proliferation ( Supplementary Fig. 6 ). In contrast to our finding of increased ERK phosphorylation after 27 β-Catenin activation in normal tissue, p-ERK levels were lower in adenomatous spheroids compared 28 to normal tissue organoids (Fig. 5E) . These experiments indicate that functional interactions between 29 the Wnt/-Catenin and MAPK pathways in the intestine may be different in normal and 30 adenomatous tissue. Dosage-and cell type-dependence of ERK phosphorylation in response to KRAS G12V in 12 CRC cell lines 13 Our data indicate that signals transduced from KRAS to ERK are context dependent and thus may be 14 subject to adaptation during CRC progression. To test this hypothesis, we compared ERK 15 phosphorylation in response to KRAS G12V or BRAF V600E in two CRC cell lines that have no mutations in 1 KRAS, NRAS or BRAF. For this, SW48 and Caco2 cells were transfected with inducible expression 2 vectors for tdTomato-KRAS G12V , -BRAF V600E , or -FLUC control, as previously used in the organoid 3 cultures. 24h after induction, cells were fixed and oncogene levels, as extrapolated from tdTomato, 4 and phosphorylation of ERK were measured via flow cytometry (Fig. 6A ). We found that even low 5 levels of BRAF V600E strongly increased ERK phosphorylation in both cell lines. In contrast, the ability of 6 KRAS G12V to induce ERK phosphorylation was markedly different (Fig. 6B) . In Caco2 cells, ERK 7 phosphorylation increased step-wisely with KRAS G12V -associated fluorescence, whereas in SW48 even 8 high levels of transgenic tdTomato-KRAS G12V were unable to induce strong ERK phosphorylation. Discussion 1 By combining reporter assays and single cell RNA sequencing in transgenic intestinal organoids, we 2 demonstrate that phosphorylation of ERK, the terminal kinase of the MAPK module, is regulated in a 3 differential and cell typic-specific manner in response to KRAS G12V or BRAF V600E . Both oncogenes 4 therefore also differed in their abilities to induce cancer-associated phenotypes, such as loss of 5 epithelial integrity and cell proliferation. 6
Importantly, we found that the ability of KRAS G12V to activate ERK was cell type-specific within the 7 intestinal epithelium and divergent between CRC cell lines. This unexpected heterogeneity in MAPK 8 signal transduction extends our understanding of how mutated KRAS, the most prevalent oncogene 9 in CRC, exerts its effects. Importantly, local differences of ERK activity have recently been found in 10 clinical specimens of CRC, including in . ERK levels were generally higher in 11 cancer cells adjacent to stromal cells at the invasive front, and lower in more central areas of the 12 cancer specimen, in line with modulation of ERK activity by cues from the microenvironment. Our 13 results agree with the view of a dynamic MAPK pathway in the presence of oncogenic KRAS. 14 However, we find here that ERK activity was turned off in differentiated enterocytes in organoid 15 culture, even in the presence of extracellular EGF. Therefore, ERK activity in the presence of 16 oncogenic KRAS can be regulated by both, external signals received from the microenvironment and 17 intrinsic cellular differentiation states. 18
We found that Paneth cells and enterocytes represent main differentiated cell types of the intestinal 19 epithelium with marked differences in their abilities to activate ERK following oncogenic activation of 20 KRAS. It is of note that the former reside in the crypt compartment with high Wnt/-Catenin activity, 21 while the latter inhabit the villus with low -Catenin activity. We therefore suggest that Wnt/-22
Catenin is among the signals in the microenvironment that could regulate ERK activity in the intestine 23 and in CRC. Indeed, a functional role for Wnt/-Catenin in the activation of ERK in the intestinal 24 epithelium has been proposed before [43] . 25
We found that KRAS G12V cooperated with oncogenic -Catenin in the induction of ERK activity, and 26 that ERK activity in the normal intestine was reduced after removal of the Wnt/-Catenin co-27 activator R-Spondin. Spheroid cells resembling intestinal adenoma were rendered EGF-independent 28 by KRAS G12V induction, in contrast to normal mouse intestinal epithelium, where KRAS G12V was not 29 sufficient to support proliferation. These findings could explain why oncogenic KRAS cannot initiate 30 tumour development in the intestine, but nevertheless is the most frequent oncogenic event 31 immediately after activation of Wnt/-Catenin in the conventional tumour progression route leading 32 to CRC [9, 10] . In this model, oncogenic KRAS provides sufficient pro-proliferative ERK activity only 1 after -Catenin activation, such as by the loss of the tumour suppressor APC. 2
In our experiments, signal transduction from BRAF to ERK was independent of cellular context. 3
Extending previous studies [27, 28] , we found that high levels of MAPK induced by oncogenic 4 BRAF V600E are not tolerated in the intestinal epithelium. This is in contrast to CRC and cell lines, where 5 BRAF V600E amplifications exist and are selected for by MEK inhibition [44, 45] . It thus appears that the 6 corridor for acceptable MAPK activity is tuneable during CRC progression and under selective 7 pressure exerted, for instance, by targeted therapy. Therefore, our findings are reminiscent of the 8 "just right" signalling model that has been proposed to explain step-wise increases of -Catenin 9 activity in CRC progression [46] . 10
We found that Caco2 cells phosphorylated ERK stepwisely when induced with increasing doses of 11 KRAS G12V , while no such response was observed in SW48 cells. This suggests that subgroups of CRC 12 could differ in their regulation of ERK activity, even when harbouring the same oncogene in the 13 MAPK pathway. This finding could explain part of the heterogeneity observed in response to anti-14 EGFR-therapy in the clinic, even after stratification of patients for mutations in KRAS, NRAS and BRAF 15 [13] . Furthermore, we found that the cellular differentiation state and activity of Wnt/-Catenin 16 could modulate ERK phosphorylation and the ERK-dependent proliferative response in intestinal 17 cells. Our findings thus suggest that controlling cellular differentiation or targeting morphogenetic 18 signalling pathways such as Wnt/-Catenin could represent a means to inhibit oncogenic MAPK 19 activity in subgroups of KRAS/BRAF-wildtype and KRAS-mutant, but not in BRAF-mutant CRCs. 20
Materials and Methods
1 Generation of transgenic mice 2 Transgene cassettes were constructed by linking tdTomato to human BRAF(V600E), KRAS(G12V) 3 and/or murine stabilized mutant Ctnnb1 (S33A, S37A, T41A, S45A) or firefly luciferase via 2A 4 peptides, and subsequent cloning of these gene combinations into a doxycycline-inducible 5 expression cassette flanked by heterologous loxP sites, and integrated into a previously modified 6 Gt(ROSA)26Sor locus of F1 hybrid B6/129S6 embryonic stem cells by Cre recombinase-mediated 7 cassette exchange, as described previously [26] . Transgenic animal production was approved by 8
Berlin authorities LAGeSo (G0185/09, G0143/14). 9
Cell and Organoid culture and protein analysis 10
Organoid cultures were initiated and propagated as described before [25] , using 48-well plates with 11 15 µl droplets of Matrigel (Corning) per well overlaid with 300 µl crypt culture medium containing 12 EGF (50 ng/ml), Noggin (100 ng/ml) and R-Spondin1 (functionally tested from R-Spondin-conditioned 13 medium; CCM-REN). Transgenes were induced by addition of 2 µg/ml doxycycline to the medium. For 14 spheroid cultures, R-Spondin was removed after induction of a transgene endoding -Catenin stab 15 alone or in combination with KRAS G12V . During passaging, spheroids were dissociated with TrypLE 16 (Gibco) for 3 min and Rho kinase inhibitor Y27632 (10 μM) was added to the culture medium to 17 prevent anoikis. The following inhibitors (SelleckChem) were employed: AZD6244 (10 μM), BVD-523 18 (3 μM), AZD8931 (50 nm), Gefitinib (1 μm). 19
Organoid and spheroid survival was scored as follows: cultures were passaged, inhibitors and 20 doxycycline were applied to the culture medium directly after passaging. Individual wells were 21 imaged using the z-stack function of Biozero observation and analyser software (Keyence) on day 1 22 and 4 (organoids) or day 1 and 6 (spheroids), and full focus-reconstructed images were used for 23 quantification. 24
For viral transfection, a protocol from reference [48] was employed, with modifications: organoids 25 were cultured in the presence of Y27632 and the GSK3 inhibitor CHIR99021 for two days. Next, 26 organoids were disaggregated into single cells using TrypLE (Gibco) for 5min. at 37°C. Cell 27 suspensions were spin-oculated in an ultra-low adhesion round bottom 96-well plate with the virus 28 at 300 g for 45min. Subsequently, cells were resuspended in Matrigel, and cultured for 2 days in 29 CCM-REN supplemented with Y27632 and CHIR99021. Subsequently, medium was replaced by CCM-30 REN containing 2 μg/ml Puromycin to select for transfected cells. As viral transfection initially 31 resulted in organoid pools that were heterogeneous for FIRE reporter activity, single FIRE positive 32 organoids were manually selected and propagated before experimental analysis. 33
Protein sample preparation and quantification of pERK was performed as previously described [47] 1 using a WES capillary system (12-230 kD Master kit α-Rabbit-HRP; PS-MK01; Protein Simple) and the 2 antibody pERK/2(T202/Y204) (1:50; #9101, Cell Signal). Raw pERK values were normalized to vinculin 3 (1:30; #4650; Cell Signal). 4
Immunohistochemistry was done on paraformaldehyde fixed and paraffin-embedded tissues. 5
Organoids were fixed in 4% paraformaldehyde for 30 minutes, while intestines were fixed over night 6 at room temperature. Subsequently, tissues were dehydrated in a graded ethanol series, followed by 7 xylene. Tissues were paraffine-embedded, sectioned at 4µm and mounted on Superfrost Plus slides 8 (Thermo Fisher Scientific). Sections were deparaffinised, rehydrated, bleached for 10 min. in 3% 9 H 2 O 2 . Antigens were retrieved using 10mM Na-citrate, pH 6 for 20 minutes at boiling temperature. 10
The following antibodies were used: Phospho-ERK (T202/Y204; #4370 Cell Signal); anti- RFP (1:200; WTA Kit (BD) with pre-dispensed library chemistry using a BD FACSAriaII SORP (BD) and a gating 28 strategy as displayed in Supplementary Figure 3 . Cells were sorted into quadrants of plates to 29 minimize batch effects between plates. For later analysis of CD44 positivity of the subsets, sorts were 30 performed as index sorts. 31
RNA sequencing and bioinformatic analyses 1
For single cell RNA sequencing, the Precise WTA Kit (BD) was used, according to the manufacturers´ 2 instructions. Sequences were produced using NextSeq and/or HiSeq chemistry (Illumina). Cluster 3 generation on NextSeq 500 followed the instructions of the manufacturer, at a final loading 4 concentration of 2 pM on a High-Output-Flowcell. 1% PhiX was added as quality control, at least 5 4x10 7 paired reads per pool were gained during a Paired-End-75 run. Library-pools running on the 6
HiSeq4000-system were prepared according to Illumina recommendations, loaded with 200 pM and 7 sequenced during a Paired-End-75 run. Again, 1% PhiX was added as quality control, and at least 8 4x10 7 read-pairs per pool were targeted. 9
Single cell RNA-sequencing data was pre-processed using the BD Precise Whole Transcriptome Assay 10 Analysis Pipeline v2.0 [51]. Quality control was performed using scater [52] . Read counts were 11 normalised using the trimmed mean of median values (TMM) approach provided with edgeR [53] . 12
Normalised read counts were used for k-means clustering and t-SNE visualisation. Differentiation 13 trajectories in t-SNE plots were determined using slingshot [54] , with intestinal stem cell cluster 1 as 14 predefined origin. Differentially expressed genes were called on log-transformed raw counts using a 15 hurdle model provided with R package MAST [55]. Top-10 signature genes per cluster were identified 16 by comparing average gene expressions within cluster to average gene expressions across all other 17 clusters. For bulk cell RNA sequencing, organoids were induced for 24 h with 2 µg/ml doxycycline in 18 CCM-REN medium and subsequently dissociated, as described before [47] . RNA-seq reads were 19 aligned to the mouse genome GRCm38 using STAR aligner with GENCODE annotation vM11. 20
Differentially expressed genes were called using DESeq2. scRNA-seq and bulk RNA-seq data are 21 available in the GEO repository under accession numbers GSE115242 and GSE115234, respectively. 
